Tuesday, 27 December 2011

Fluxal




Fluxal may be available in the countries listed below.


Ingredient matches for Fluxal



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluxal in the following countries:


  • Dominican Republic

  • India

International Drug Name Search

Wednesday, 21 December 2011

Therapelcin




Therapelcin may be available in the countries listed below.


Ingredient matches for Therapelcin



Cimetidine

Cimetidine is reported as an ingredient of Therapelcin in the following countries:


  • Ethiopia

International Drug Name Search

Sunday, 18 December 2011

Laktulos Merck NM




Laktulos Merck NM may be available in the countries listed below.


Ingredient matches for Laktulos Merck NM



Lactulose

Lactulose is reported as an ingredient of Laktulos Merck NM in the following countries:


  • Finland

International Drug Name Search

Friday, 16 December 2011

Nogacid-D




Nogacid-D may be available in the countries listed below.


Ingredient matches for Nogacid-D



Domperidone

Domperidone is reported as an ingredient of Nogacid-D in the following countries:


  • India

Omeprazole

Omeprazole is reported as an ingredient of Nogacid-D in the following countries:


  • India

International Drug Name Search

Wednesday, 14 December 2011

Asolmicina.Dox




Asolmicina.Dox may be available in the countries listed below.


Ingredient matches for Asolmicina.Dox



Doxycycline

Doxycycline is reported as an ingredient of Asolmicina.Dox in the following countries:


  • Argentina

International Drug Name Search

Friday, 9 December 2011

Sanctura


See also: Generic Sanctura XR


Sanctura is a brand name of trospium, approved by the FDA in the following formulation(s):


SANCTURA (trospium chloride - tablet; oral)



  • Manufacturer: ALLERGAN

    Approval date: May 28, 2004

    Strength(s): 20MG [RLD][AB]

Has a generic version of Sanctura been approved?


Yes. The following products are equivalent to Sanctura:


trospium chloride tablet; oral



  • Manufacturer: APOTEX

    Approval date: December 6, 2011

    Strength(s): 20MG [AB]


  • Manufacturer: GLENMARK GENERICS

    Approval date: August 13, 2010

    Strength(s): 20MG [AB]


  • Manufacturer: PADDOCK LLC

    Approval date: November 17, 2010

    Strength(s): 20MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sanctura. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Sanctura.

See also...

  • Sanctura Consumer Information (Drugs.com)
  • Sanctura Consumer Information (Wolters Kluwer)
  • Sanctura Consumer Information (Cerner Multum)
  • Sanctura Advanced Consumer Information (Micromedex)
  • Sanctura AHFS DI Monographs (ASHP)
  • Trospium Consumer Information (Wolters Kluwer)
  • Trospium Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Trospium Consumer Information (Cerner Multum)
  • Trospium Advanced Consumer Information (Micromedex)
  • Trospium Chloride AHFS DI Monographs (ASHP)

Saturday, 3 December 2011

Bipomax




Bipomax may be available in the countries listed below.


Ingredient matches for Bipomax



Topiramate

Topiramate is reported as an ingredient of Bipomax in the following countries:


  • Spain

International Drug Name Search

Todol




Todol may be available in the countries listed below.


Ingredient matches for Todol



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Todol in the following countries:


  • Bangladesh

International Drug Name Search

Friday, 2 December 2011

Carbamazepin Aristo




Carbamazepin Aristo may be available in the countries listed below.


Ingredient matches for Carbamazepin Aristo



Carbamazepine

Carbamazepine is reported as an ingredient of Carbamazepin Aristo in the following countries:


  • Germany

International Drug Name Search

Wednesday, 16 November 2011

Prednip




Prednip may be available in the countries listed below.


Ingredient matches for Prednip



Prednisolone

Prednisolone is reported as an ingredient of Prednip in the following countries:


  • Sri Lanka

International Drug Name Search

Saturday, 12 November 2011

Robax Platinum




Robax Platinum may be available in the countries listed below.


Ingredient matches for Robax Platinum



Ibuprofen

Ibuprofen is reported as an ingredient of Robax Platinum in the following countries:


  • Canada

Methocarbamol

Methocarbamol is reported as an ingredient of Robax Platinum in the following countries:


  • Canada

International Drug Name Search

Wednesday, 9 November 2011

Desmopressine-acetaat Sandoz




Desmopressine-acetaat Sandoz may be available in the countries listed below.


Ingredient matches for Desmopressine-acetaat Sandoz



Desmopressin

Desmopressin acetate (a derivative of Desmopressin) is reported as an ingredient of Desmopressine-acetaat Sandoz in the following countries:


  • Netherlands

International Drug Name Search

Monday, 7 November 2011

Carvasin




Carvasin may be available in the countries listed below.


Ingredient matches for Carvasin



Isosorbide Dinitrate

Isosorbide Dinitrate is reported as an ingredient of Carvasin in the following countries:


  • Italy

International Drug Name Search

Friday, 4 November 2011

Simvastatin STADA




Simvastatin STADA may be available in the countries listed below.


Ingredient matches for Simvastatin STADA



Simvastatin

Simvastatin is reported as an ingredient of Simvastatin STADA in the following countries:


  • Germany

  • Sweden

  • Vietnam

International Drug Name Search

Prednitop




Prednitop may be available in the countries listed below.


Ingredient matches for Prednitop



Prednicarbate

Prednicarbate is reported as an ingredient of Prednitop in the following countries:


  • Austria

  • Germany

  • Switzerland

International Drug Name Search

Tuesday, 25 October 2011

Normopresan




Normopresan may be available in the countries listed below.


Ingredient matches for Normopresan



Clonidine

Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Normopresan in the following countries:


  • Israel

International Drug Name Search

Friday, 14 October 2011

Mucolisin




Mucolisin may be available in the countries listed below.


Ingredient matches for Mucolisin



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Mucolisin in the following countries:


  • Georgia

Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Mucolisin in the following countries:


  • Ecuador

International Drug Name Search

Saturday, 8 October 2011

Fluvastatine




Fluvastatine may be available in the countries listed below.


Ingredient matches for Fluvastatine



Fluvastatin

Fluvastatine (DCF) is known as Fluvastatin in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 4 October 2011

Niflactol




Niflactol may be available in the countries listed below.


Ingredient matches for Niflactol



Niflumic Acid

Niflumic Acid is reported as an ingredient of Niflactol in the following countries:


  • Spain

International Drug Name Search

Monday, 3 October 2011

Ranitidine 75 Drug Facts




Dosage Form: tablet
Major Pharmaceuticals Ranitidine 75 Tablets Drug Facts

Active ingredient (in each tablet)


Ranitidine 75 mg (as ranitidine hydrochloride 84 mg)



Purpose


Acid reducer



Uses


  • relieves heartburn associated with acid indigestion and sour stomach

  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages


Warnings


Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers



Do not use


  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.

  • with other acid reducers


Ask a doctor before use if you have


  • frequent chest pain

  • frequent wheezing, particularly with heartburn

  • unexplained weight loss

  • nausea or vomiting

  • stomach pain

  • had heartburn over 3 months. This may be a sign of a more serious condition

  • heartburn with lightheadedness, sweating or dizziness

  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness


Stop use and ask a doctor if


  • your heartburn continues or worsens

  • you need to take this product for more than 14 days


If pregnant or breast-feeding,


ask a health professional before use.



Keep out of reach of children.


In case of overdose, get medical help or contact a Poison Control Center right away.



Directions


  • adults and children 12 years and over:

  • to relieve symptoms, swallow 1 tablet with a glass of water

  • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn

  • can be used up to twice daily (do not take more than 2 tablets in 24 hours)

  • children under 12 years: ask a doctor


Other information


  • do not use if printed foil under cap is broken or missing

  • store at 20° - 25°C (68° - 77°F)

  • avoid excessive heat or humidity

  • this product is sugar free


Inactive ingredients


colloidal silicon dioxide, croscarmellose sodium, diethyl phthalate, hypromellose, iron oxide red, magnesium stearate, microcrystalline cellulose, titanium dioxide.



Questions or comments?


1-800-719-9260



Principal Display Panel


Ranitidine 75


Ranitidine Tablets, 75 mg


Acid Reducer


One Tablet Relieves and Prevents:


Heartburn Associated with Acid Indigestion and Sour Stomach


Compare to the active ingredient of Zantac 75®


# Doses {Replace "#" with number tablets in package}


Ranitidine 75 Tablets Carton










RANITIDINE 75 
ranitidine  tablet










Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)0904-5818
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RANITIDINE HYDROCHLORIDE (RANITIDINE)RANITIDINE75 mg





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
ColorPINKScoreno score
ShapeHEXAGON (6 sided)Size8mm
FlavorImprint CodeW75
Contains      






















Packaging
#NDCPackage DescriptionMultilevel Packaging
10904-5818-461 BOTTLE In 1 CARTONcontains a BOTTLE
130 TABLET In 1 BOTTLEThis package is contained within the CARTON (0904-5818-46)
20904-5818-521 BOTTLE In 1 CARTONcontains a BOTTLE
260 TABLET In 1 BOTTLEThis package is contained within the CARTON (0904-5818-52)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07676005/26/2009


Labeler - Major Pharmaceuticals (191427277)
Revised: 07/2009Major Pharmaceuticals




More Ranitidine 75 Drug Facts resources


  • Ranitidine 75 Drug Facts Dosage
  • Ranitidine 75 Drug Facts Use in Pregnancy & Breastfeeding
  • Drug Images
  • Ranitidine 75 Drug Facts Drug Interactions
  • Ranitidine 75 Drug Facts Support Group
  • 32 Reviews for Ranitidine 75 Drug Facts - Add your own review/rating


Compare Ranitidine 75 Drug Facts with other medications


  • Duodenal Ulcer
  • Duodenal Ulcer Prophylaxis
  • Erosive Esophagitis
  • Gastric Ulcer Maintenance Treatment
  • Gastrointestinal Hemorrhage
  • GERD
  • Indigestion
  • Pathological Hypersecretory Conditions
  • Stomach Ulcer
  • Stress Ulcer Prophylaxis
  • Surgical Prophylaxis
  • Zollinger-Ellison Syndrome

Monday, 26 September 2011

Phoxim




In some countries, this medicine may only be approved for veterinary use.

Scheme

Prop.INN

CAS registry number (Chemical Abstracts Service)

0014816-18-3

Chemical Formula

C12-H15-N2-O3-P-S

Molecular Weight

298

Therapeutic Category

Anthelmintic

Chemical Name

3,5-Dioxa-6-aza-4-phosphaoct-6-ene-8-nitrile, 4-ethoxy-7-phenyl-, 4-sulfide

Foreign Names

  • Phoximum (Latin)
  • Phoxim (German)
  • Phoxime (French)
  • Foxima (Spanish)

Generic Names

  • Phoxim (OS: BAN)
  • Bayer 77488 (IS)
  • Bayer 9053 (IS)
  • SRA 7502 (IS)

Brand Names

  • Byemite (veterinary use)
    Bayer Santé Animale Division Santé Animale, France


  • Sarnacuran (veterinary use)
    Bayer Animal Health, Belgium


  • Sebacil (veterinary use)
    Bayer, Sweden; Bayer Animal, Germany; Bayer Animal, Norway; Bayer Portugal, SA., Portugal; Bayer Sanità Animale, Italy; Bayer Santé Animale Division Santé Animale, France; Bayer Tiergesundheit, Austria; Provet, Switzerland

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Biopen VK




Biopen VK may be available in the countries listed below.


Ingredient matches for Biopen VK



Phenoxymethylpenicillin

Phenoxymethylpenicillin potassium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Biopen VK in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, 24 September 2011

Spiramastin




Spiramastin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Spiramastin



Spiramycin

Spiramycin adipate (a derivative of Spiramycin) is reported as an ingredient of Spiramastin in the following countries:


  • Switzerland

International Drug Name Search

Tuesday, 20 September 2011

Dogmatyl




Dogmatyl may be available in the countries listed below.


Ingredient matches for Dogmatyl



Sulpiride

Sulpiride is reported as an ingredient of Dogmatyl in the following countries:


  • Greece

  • Japan

  • Taiwan

International Drug Name Search

Sunday, 18 September 2011

Tykerb




In the US, Tykerb (lapatinib systemic) is a member of the following drug classes: EGFR inhibitors, HER2 inhibitors and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:

  • Tykerb

Ingredient matches for Tykerb



Lapatinib

Lapatinib ditosylate (a derivative of Lapatinib) is reported as an ingredient of Tykerb in the following countries:


  • Australia

  • Indonesia

  • Japan

  • New Zealand

  • Oman

  • United States

International Drug Name Search

Lofepramine Hydrochloride




Lofepramine Hydrochloride may be available in the countries listed below.


Ingredient matches for Lofepramine Hydrochloride



Lofepramine

Lofepramine Hydrochloride (BANM, JAN, USAN) is also known as Lofepramine (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 11 September 2011

Verapress SR




Verapress SR may be available in the countries listed below.


Ingredient matches for Verapress SR



Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Verapress SR in the following countries:


  • Israel

International Drug Name Search

Relenza


Pronunciation: zan-AM-i-vir
Generic Name: Zanamivir
Brand Name: Relenza


Relenza is used for:

Treating influenza, including H1N1 influenza (swine flu), in patients 7 years old and older who have had symptoms for no more than 2 days. It may also be used to prevent influenza in patients 5 years old and older.


Relenza is an antiviral agent. It works by blocking the growth and spread of respiratory viruses.


Do NOT use Relenza if:


  • you are allergic to any ingredient in Relenza, to lactose, or to milk protein

  • you are going to have an intranasal live attenuated influenza vaccine (LAIV) within the next 2 days or you have had such a vaccine within the past 2 weeks

Contact your doctor or health care provider right away if any of these apply to you.



Before using Relenza:


Some medical conditions may interact with Relenza. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have heart problems, lung or breathing problems (eg, asthma, chronic obstructive pulmonary disease [COPD], emphysema), or if you have a lung infection

  • if you have a history of mental or mood problems

Some MEDICINES MAY INTERACT with Relenza. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Intranasal live attenuated influenza vaccine (LAIV ) because its effectiveness may be decreased by Relenza

This may not be a complete list of all interactions that may occur. Ask your health care provider if Relenza may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Relenza:


Use Relenza as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Relenza. Talk to your pharmacist if you have questions about this information.

  • Follow instructions given to you by your doctor, pharmacist, or health care provider for using the medicine delivery device.

  • Do not puncture the medicine blister until you are ready to take a dose.

  • Continue Relenza for the full course of treatment even if you feel better in a few days. Do not miss any doses.

  • If you have lung or breathing problems (eg, asthma, COPD) and you have a dose of a bronchodilator inhaler (eg, albuterol) scheduled at the same time as Relenza, use the bronchodilator before using Relenza. Be sure to always carry a fast-acting bronchodilator inhaler with you to use in case of bronchospasm while using Relenza.

  • If you miss a dose of Relenza, use it as soon as possible. If it is almost time for your next dose (within 2 hours), skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once. If more than 1 dose is missed, contact your doctor or pharmacist.

Ask your health care provider any questions you may have about how to use Relenza.



Important safety information:


  • Relenza may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Relenza with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Relenza will not prevent you from spreading influenza to others.

  • Relenza should not be used in place of the influenza vaccine recommended by the Centers for Disease Control and Prevention (CDC).

  • Relenza works only against the influenza virus; it does not treat bacterial or other viral infections.

  • Patients with the flu who take Relenza may have an increased risk of confusion and unusual behavioral changes. The risk may be greater in children. Contact your doctor if you notice symptoms of confusion or any other unusual behavioral changes.

  • Tell your doctor or dentist that you take Relenza before you receive any medical or dental care, emergency care, or surgery.

  • Tell your doctor that you take Relenza before you receive any vaccines, including the intranasal live attenuated influenza vaccine (LAIV).

  • Contact your doctor at once if you have lung or breathing problems (eg, asthma, COPD) and your symptoms become worse, or if you have problems breathing, such as wheezing or shortness of breath, or other signs of bronchospasm.

  • If your symptoms do not get better within a few days or if they get worse, check with your doctor.

  • Lab tests, including lung function, may be performed while you use Relenza. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Caution is advised when using Relenza in CHILDREN; they may be more sensitive to its effects, especially seizures, confusion, and abnormal behavior.

  • Relenza should be used with extreme caution in CHILDREN younger than 5 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY AND BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Relenza while you are pregnant. It is not known if Relenza is found in breast milk. If you are or will be breast-feeding while you use Relenza, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Relenza:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Cough; diarrhea; dizziness; headache; nausea; sinus inflammation; sore throat; stuffy nose; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue); abnormal behavior; confusion; hallucinations; irregular heartbeat; mood or mental changes; rash with fever, mouth sores, or red and irritated eyes; red, swollen, blistered, or peeling skin; seizures; shortness of breath; symptoms of infection (eg, fever, chills, persistent sore throat); trouble swallowing; wheezing.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Relenza side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Relenza:

Store Relenza at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Do not puncture the blister until you are ready to take a dose using the Diskhaler. Keep Relenza out of the reach of children and away from pets.


General information:


  • If you have any questions about Relenza, please talk with your doctor, pharmacist, or other health care provider.

  • Relenza is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Relenza. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Relenza resources


  • Relenza Side Effects (in more detail)
  • Relenza Use in Pregnancy & Breastfeeding
  • Relenza Drug Interactions
  • Relenza Support Group
  • 2 Reviews for Relenza - Add your own review/rating


  • Relenza Prescribing Information (FDA)

  • Relenza Consumer Overview

  • Relenza Monograph (AHFS DI)

  • Relenza Advanced Consumer (Micromedex) - Includes Dosage Information

  • Zanamivir Professional Patient Advice (Wolters Kluwer)



Compare Relenza with other medications


  • Influenza
  • Influenza Prophylaxis
  • Swine Flu

Saturday, 27 August 2011

Garalone




Garalone may be available in the countries listed below.


Ingredient matches for Garalone



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Garalone in the following countries:


  • Portugal

International Drug Name Search

Thursday, 18 August 2011

Cimetidin acis




Cimetidin acis may be available in the countries listed below.


Ingredient matches for Cimetidin acis



Cimetidine

Cimetidine is reported as an ingredient of Cimetidin acis in the following countries:


  • Germany

International Drug Name Search

Wednesday, 17 August 2011

Ketotifeno Genfar




Ketotifeno Genfar may be available in the countries listed below.


Ingredient matches for Ketotifeno Genfar



Ketotifen

Ketotifen is reported as an ingredient of Ketotifeno Genfar in the following countries:


  • Colombia

  • Ecuador

  • Peru

International Drug Name Search

Tuesday, 16 August 2011

Mucodyne DS




Mucodyne DS may be available in the countries listed below.


Ingredient matches for Mucodyne DS



Carbocisteine

Carbocisteine is reported as an ingredient of Mucodyne DS in the following countries:


  • Japan

International Drug Name Search

Sunday, 14 August 2011

Pindol




Pindol may be available in the countries listed below.


Ingredient matches for Pindol



Pindolol

Pindolol is reported as an ingredient of Pindol in the following countries:


  • New Zealand

International Drug Name Search

Saturday, 13 August 2011

Amufast




Amufast may be available in the countries listed below.


Ingredient matches for Amufast



Loperamide

Loperamide is reported as an ingredient of Amufast in the following countries:


  • Vietnam

International Drug Name Search

Thursday, 4 August 2011

Zoxon




Zoxon may be available in the countries listed below.


Ingredient matches for Zoxon



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Zoxon in the following countries:


  • Czech Republic

  • Estonia

  • Latvia

  • Lithuania

  • Poland

  • Romania

  • Russian Federation

  • Slovakia

International Drug Name Search

Decozol




Decozol may be available in the countries listed below.


Ingredient matches for Decozol



Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Decozol in the following countries:


  • Ethiopia

  • Myanmar

  • Singapore

International Drug Name Search

Sunday, 31 July 2011

Manidilot




Manidilot may be available in the countries listed below.


Ingredient matches for Manidilot



Manidipine

Manidipine dihydrochloride (a derivative of Manidipine) is reported as an ingredient of Manidilot in the following countries:


  • Japan

International Drug Name Search

Monday, 25 July 2011

Capomil




Capomil may be available in the countries listed below.


Ingredient matches for Capomil



Captopril

Captopril is reported as an ingredient of Capomil in the following countries:


  • Taiwan

International Drug Name Search

Sunday, 24 July 2011

Primonil




Primonil may be available in the countries listed below.


Ingredient matches for Primonil



Imipramine

Imipramine hydrochloride (a derivative of Imipramine) is reported as an ingredient of Primonil in the following countries:


  • Israel

International Drug Name Search

Wednesday, 20 July 2011

Sulpin




Sulpin may be available in the countries listed below.


Ingredient matches for Sulpin



Sulpiride

Sulpiride is reported as an ingredient of Sulpin in the following countries:


  • Taiwan

International Drug Name Search

Tuesday, 19 July 2011

Dolofin




Dolofin may be available in the countries listed below.


Ingredient matches for Dolofin



Ibuprofen

Ibuprofen is reported as an ingredient of Dolofin in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Thursday, 14 July 2011

Pulmax




Pulmax may be available in the countries listed below.


Ingredient matches for Pulmax



Budesonide

Budesonide is reported as an ingredient of Pulmax in the following countries:


  • Czech Republic

  • Estonia

  • Germany

  • Hungary

International Drug Name Search

Monday, 4 July 2011

Tankaru




Tankaru may be available in the countries listed below.


Ingredient matches for Tankaru



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Tankaru in the following countries:


  • Japan

International Drug Name Search

Sunday, 3 July 2011

Kenicef




Kenicef may be available in the countries listed below.


Ingredient matches for Kenicef



Cefodizime

Cefodizime disodium salt (a derivative of Cefodizime) is reported as an ingredient of Kenicef in the following countries:


  • Japan

International Drug Name Search

Saturday, 25 June 2011

Trerief




Trerief may be available in the countries listed below.


Ingredient matches for Trerief



Zonisamide

Zonisamide is reported as an ingredient of Trerief in the following countries:


  • Japan

International Drug Name Search

Tuesday, 21 June 2011

Doxyvet




Doxyvet may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Doxyvet



Doxycycline

Doxycycline hydrochloride (a derivative of Doxycycline) is reported as an ingredient of Doxyvet in the following countries:


  • Australia

International Drug Name Search

Friday, 17 June 2011

BP 10-Wash


Generic Name: sulfacetamide sodium and sulfur topical (SUL fa SEET a mide SOE dee um and SUL fur TOP i kal)

Brand Names: Avar Cleanser, Avar Gel, Avar LS Cleanser, Avar-E, Avar-E Emollient, Avar-E Green, Avar-e LS, BP 10-Wash, Clarifoam EF, Clenia Emollient Cream, Clenia Foaming Wash, Plexion , Plexion Cleanser, Plexion Cleansing Cloths, Plexion SCT, Prascion, Prascion Cleanser, Prascion FC Cloths, Prascion RA, Rosac, Rosac Wash, Rosaderm Cleanser, Rosanil Cleanser, Rosula, SE 10-5 SS, Sulfacet-R, Sulfatol C, Sulfatol SS, SulZee Wash, Sumaxin, Sumaxin TS, Sumaxin Wash, Suphera, Topisulf, Zencia Wash, Zetacet


What is BP 10-Wash (sulfacetamide sodium and sulfur topical)?

Sulfacetamide sodium and sulfur are antibiotic that fight bacteria.


The combination of sulfacetamide sodium and sulfur topical (for the skin) is used to treat acne, rosacea, and seborrheic dermatitis (a red, flaking skin rash).


Sulfacetamide sodium and sulfur topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about BP 10-Wash (sulfacetamide sodium and sulfur topical)?


You should not use this medication if you are allergy to sulfa drugs or if you have kidney disease. Avoid getting this medication in your eyes, nose, or mouth. If this does happen, rinse with water.

Do not cover the treated skin area unless your doctor has told you to.


Avoid using other medications on the areas you treat with sulfacetamide sodium and sulfur topical unless you doctor tells you to.

What should I discuss with my healthcare provider before using BP 10-Wash (sulfacetamide sodium and sulfur topical)?


You should not use this medication if you are allergy to sulfa drugs or if you have kidney disease.

To make sure you can safely use this medication, tell your doctor about all of your medical conditions.


FDA pregnancy category C. It is not known whether sulfacetamide sodium and sulfur topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether sulfacetamide sodium and sulfur topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use BP 10-Wash (sulfacetamide sodium and sulfur topical)?


Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Wash your hands before and after applying this medication.

Do not cover the treated skin area unless your doctor has told you to.


Use this medication regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.


Store at room temperature away from moisture and heat.

What happens if I miss a dose?


Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.


What should I avoid while using BP 10-Wash (sulfacetamide sodium and sulfur topical)?


Avoid getting this medication in your eyes, nose, or mouth. If this does happen, rinse with water. Do not use sulfacetamide sodium and sulfur topical on sunburned, windburned, dry, chapped, irritated, or broken skin.

Avoid using other medications on the areas you treat with sulfacetamide sodium and sulfur topical unless you doctor tells you to.


BP 10-Wash (sulfacetamide sodium and sulfur topical) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have a serious side effect such as:

  • new or worsening skin rash;




  • joint pain;




  • fever; or




  • mouth sores.



Less serious side effects may include redness, warmth, swelling, itching, stinging, burning, or irritation of treated skin.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect BP 10-Wash (sulfacetamide sodium and sulfur topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied sulfacetamide sodium and sulfur. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More BP 10-Wash resources


  • BP 10-Wash Use in Pregnancy & Breastfeeding
  • BP 10-Wash Drug Interactions
  • 0 Reviews for BP0-Wash - Add your own review/rating


  • Avar LS Cleanser MedFacts Consumer Leaflet (Wolters Kluwer)

  • Clarifoam EF Foam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Clarifoam EF Prescribing Information (FDA)

  • Plexion Prescribing Information (FDA)

  • Plexion Cleansing Cloths MedFacts Consumer Leaflet (Wolters Kluwer)

  • Plexion SCT Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Plexion TS Emulsion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Prascion Cleanser Prescribing Information (FDA)

  • Rosac Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rosaderm Cleanser Prescribing Information (FDA)

  • Rosanil Cleanser Prescribing Information (FDA)

  • Rosula Foam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rosula Prescribing Information (FDA)

  • Rosula Cleanser Emulsion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Sumadan MedFacts Consumer Leaflet (Wolters Kluwer)

  • Sumadan Wash Prescribing Information (FDA)

  • Sumaxin Wash MedFacts Consumer Leaflet (Wolters Kluwer)

  • Sumaxin Wash Prescribing Information (FDA)

  • Zencia Wash Prescribing Information (FDA)



Compare BP 10-Wash with other medications


  • Acne
  • Rosacea
  • Seborrheic Dermatitis


Where can I get more information?


  • Your pharmacist can provide more information about sulfacetamide sodium and sulfur topical.


Thursday, 9 June 2011

Fluxit




Fluxit may be available in the countries listed below.


Ingredient matches for Fluxit



Flupentixol

Flupentixol is reported as an ingredient of Fluxit in the following countries:


  • Bangladesh

Melitracen

Melitracen is reported as an ingredient of Fluxit in the following countries:


  • Bangladesh

International Drug Name Search

Saturday, 28 May 2011

Clebudan Aqua




Clebudan Aqua may be available in the countries listed below.


Ingredient matches for Clebudan Aqua



Budesonide

Budesonide is reported as an ingredient of Clebudan Aqua in the following countries:


  • Chile

International Drug Name Search

Tuesday, 24 May 2011

Dexketoprofen Trometamol




Dexketoprofen Trometamol may be available in the countries listed below.


Ingredient matches for Dexketoprofen Trometamol



Dexketoprofen

Dexketoprofen Trometamol (BANM) is also known as Dexketoprofen (Rec.INN)

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 19 May 2011

Sintradon




Sintradon may be available in the countries listed below.


Ingredient matches for Sintradon



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Sintradon in the following countries:


  • Serbia

International Drug Name Search

Friday, 13 May 2011

Posterisan akut




Posterisan akut may be available in the countries listed below.


Ingredient matches for Posterisan akut



Lidocaine

Lidocaine is reported as an ingredient of Posterisan akut in the following countries:


  • Germany

International Drug Name Search

Monday, 9 May 2011

Natacyn


Natacyn is a brand name of natamycin ophthalmic, approved by the FDA in the following formulation(s):


NATACYN (natamycin - suspension; ophthalmic)



  • Manufacturer: ALCON

    Approved Prior to Jan 1, 1982

    Strength(s): 5% [RLD]

Has a generic version of Natacyn been approved?


No. There is currently no therapeutically equivalent version of Natacyn available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Natacyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Natacyn.

See also...

  • Natacyn Consumer Information (Wolters Kluwer)
  • Natacyn Consumer Information (Cerner Multum)
  • Natacyn Advanced Consumer Information (Micromedex)
  • Natacyn AHFS DI Monographs (ASHP)
  • Natamycin Consumer Information (Wolters Kluwer)
  • Natamycin ophthalmic Consumer Information (Cerner Multum)
  • Natamycin Ophthalmic Advanced Consumer Information (Micromedex)
  • Natamycin AHFS DI Monographs (ASHP)

Wednesday, 4 May 2011

Robitussin Children's




Robitussin Children's may be available in the countries listed below.


Ingredient matches for Robitussin Children's



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Robitussin Children's in the following countries:


  • Canada

International Drug Name Search

Monday, 25 April 2011

Amlodipina Cardionox




Amlodipina Cardionox may be available in the countries listed below.


Ingredient matches for Amlodipina Cardionox



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipina Cardionox in the following countries:


  • Portugal

International Drug Name Search

Friday, 8 April 2011

Duphapen Strep




Duphapen Strep may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Duphapen Strep



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Duphapen Strep in the following countries:


  • France

  • Luxembourg

Dihydrostreptomycin

Dihydrostreptomycin sulfate (a derivative of Dihydrostreptomycin) is reported as an ingredient of Duphapen Strep in the following countries:


  • France

  • Luxembourg

International Drug Name Search

Saturday, 2 April 2011

Sandepril




Sandepril may be available in the countries listed below.


Ingredient matches for Sandepril



Maprotiline

Maprotiline hydrochloride (a derivative of Maprotiline) is reported as an ingredient of Sandepril in the following countries:


  • Indonesia

International Drug Name Search

Monday, 21 March 2011

Glibenclamide IPS




Glibenclamide IPS may be available in the countries listed below.


Ingredient matches for Glibenclamide IPS



Glibenclamide

Glibenclamide is reported as an ingredient of Glibenclamide IPS in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 20 March 2011

Sophanax




Sophanax may be available in the countries listed below.


Ingredient matches for Sophanax



Alprazolam

Alprazolam is reported as an ingredient of Sophanax in the following countries:


  • Bulgaria

International Drug Name Search

Sunday, 13 March 2011

Mirtazapin Imi Pharma




Mirtazapin Imi Pharma may be available in the countries listed below.


Ingredient matches for Mirtazapin Imi Pharma



Mirtazapine

Mirtazapine is reported as an ingredient of Mirtazapin Imi Pharma in the following countries:


  • Sweden

International Drug Name Search

Thursday, 10 March 2011

Furogamma




Furogamma may be available in the countries listed below.


Ingredient matches for Furogamma



Furosemide

Furosemide is reported as an ingredient of Furogamma in the following countries:


  • Estonia

  • Germany

  • Latvia

International Drug Name Search

Monday, 7 March 2011

Cipadur




Cipadur may be available in the countries listed below.


Ingredient matches for Cipadur



Cefadroxil

Cefadroxil is reported as an ingredient of Cipadur in the following countries:


  • South Africa

International Drug Name Search

Saturday, 26 February 2011

Lincocin




In some countries, this medicine may only be approved for veterinary use.


In the US, Lincocin (lincomycin systemic) is a member of the drug class lincomycin derivatives and is used to treat Bacterial Infection and Conjunctivitis - Bacterial.

US matches:

  • Lincocin

Ingredient matches for Lincocin



Lincomycin

Lincomycin is reported as an ingredient of Lincocin in the following countries:


  • Turkey

Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Lincocin in the following countries:


  • Australia

  • Austria

  • Bahrain

  • Belgium

  • Bosnia & Herzegowina

  • Canada

  • Chile

  • Colombia

  • Costa Rica

  • Ecuador

  • El Salvador

  • Finland

  • Georgia

  • Ghana

  • Greece

  • Guatemala

  • Honduras

  • Hong Kong

  • Indonesia

  • Ireland

  • Italy

  • Japan

  • Kenya

  • Latvia

  • Liberia

  • Lithuania

  • Luxembourg

  • Mexico

  • Netherlands

  • Nicaragua

  • Norway

  • Oman

  • Panama

  • Peru

  • Philippines

  • Poland

  • Romania

  • Sierra Leone

  • Singapore

  • South Africa

  • Spain

  • Tanzania

  • Thailand

  • Uganda

  • United Kingdom

  • United States

  • Venezuela

  • Vietnam

  • Zimbabwe

International Drug Name Search

Thursday, 24 February 2011

Epirubicine Hospira




Epirubicine Hospira may be available in the countries listed below.


Ingredient matches for Epirubicine Hospira



Epirubicin

Epirubicin hydrochloride (a derivative of Epirubicin) is reported as an ingredient of Epirubicine Hospira in the following countries:


  • France

International Drug Name Search

Tuesday, 22 February 2011

PrandiMet




In the US, PrandiMet (metformin/repaglinide systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.

US matches:

  • PrandiMet

Ingredient matches for PrandiMet



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of PrandiMet in the following countries:


  • United States

Pioglitazone

Pioglitazone hydrochloride (a derivative of Pioglitazone) is reported as an ingredient of PrandiMet in the following countries:


  • United States

International Drug Name Search

Monday, 21 February 2011

Alprazolam ratiopharm




Alprazolam-ratiopharm may be available in the countries listed below.


Ingredient matches for Alprazolam-ratiopharm



Alprazolam

Alprazolam is reported as an ingredient of Alprazolam-ratiopharm in the following countries:


  • Austria

  • France

  • Germany

  • Italy

  • Netherlands

  • Portugal

  • Spain

International Drug Name Search

Sunday, 20 February 2011

Norbactin




Norbactin may be available in the countries listed below.


Ingredient matches for Norbactin



Norfloxacin

Norfloxacin is reported as an ingredient of Norbactin in the following countries:


  • India

  • Latvia

  • Lithuania

  • Oman

  • Peru

  • Singapore

  • Sri Lanka

International Drug Name Search

Wednesday, 16 February 2011

Enablex


Enablex is a brand name of darifenacin, approved by the FDA in the following formulation(s):


ENABLEX (darifenacin hydrobromide - tablet, extended release; oral)



  • Manufacturer: WARNER CHILCOTT LLC

    Approval date: December 22, 2004

    Strength(s): EQ 15MG BASE [RLD], EQ 7.5MG BASE

Has a generic version of Enablex been approved?


No. There is currently no therapeutically equivalent version of Enablex available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Enablex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Pyrrolidine derivatives
    Patent 5,096,890
    Issued: March 17, 1992
    Inventor(s): Cross; Peter E. & MacKenzie; Alexander R.
    Assignee(s): Pfizer Inc.
    Compounds of the formula ##STR1## wherein R, Y and R.sup.1 are as defined in the specification. These compounds are muscarinic receptor antagonists which are selective for smooth muscle muscarinic sites over cardiac muscarinic sites, and are useful in the treatment of diseases associated with altered motility on tone of smooth muscle, including irritable bowel syndrome, diverticular disease, urinary incontinence, oesophageal achalasia and chronic obstructive airways disease.
    Patent expiration dates:

    • March 13, 2015
      ✓ 
      Patent use: TREATING A DISEASE OF ALTERED MOTILITY OR TONE OF SMOOTH MUSCLE BY ADMINISTERING A MUSCARINIC RECEPTOR ANTAGONIZING AMOUNT OF DARIFENACIN
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Pharmaceutical formulations containing darifenacin
    Patent 6,106,864
    Issued: August 22, 2000
    Inventor(s): Dolan; Thomas Francis & Humphrey; Michael John & Nichols; Donald John
    Assignee(s): Pfizer Inc.
    There is provided a pharmaceutical dosage form adapted for administration to the gastrointestinal tract of a patient, comprising darifenacin, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable adjuvant, diluent or carrier, characterized in that the dosage form is adapted to deliver at least 10% by weight of the darifenacin, or the pharmaceutically acceptable salt thereof, to the lower gastrointestinal tract of the patient. The formulation minimizes unwanted side-effects and increases the bioavailability of darifenacin.
    Patent expiration dates:

    • August 21, 2016
      ✓ 
      Patent use: TREATING URINARY INCONTINENCE BY ADMINISTERING AN EXTENDED-RELEASE FORM OF DARIFENACIN
      ✓ 
      Drug product



See also...

  • Enablex Consumer Information (Drugs.com)
  • Enablex Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Enablex Consumer Information (Cerner Multum)
  • Enablex Advanced Consumer Information (Micromedex)
  • Enablex AHFS DI Monographs (ASHP)
  • Darifenacin Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Darifenacin Consumer Information (Cerner Multum)
  • Darifenacin Advanced Consumer Information (Micromedex)
  • Darifenacin Hydrobromide AHFS DI Monographs (ASHP)

Monday, 14 February 2011

Nicotinell Lutschtabletten




Nicotinell Lutschtabletten may be available in the countries listed below.


Ingredient matches for Nicotinell Lutschtabletten



Nicotine

Nicotine bitartrate dihydrate (a derivative of Nicotine) is reported as an ingredient of Nicotinell Lutschtabletten in the following countries:


  • Switzerland

International Drug Name Search

Thursday, 10 February 2011

Divina




Divina may be available in the countries listed below.


Ingredient matches for Divina



Estradiol

Estradiol is reported as an ingredient of Divina in the following countries:


  • Tunisia

Estradiol 17ß-valerate (a derivative of Estradiol) is reported as an ingredient of Divina in the following countries:


  • Czech Republic

  • Finland

  • France

  • Greece

  • Hungary

  • Poland

  • Slovakia

  • Turkey

Medroxyprogesterone

Medroxyprogesterone is reported as an ingredient of Divina in the following countries:


  • Hungary

  • Tunisia

  • Turkey

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Divina in the following countries:


  • France

  • Greece

  • Poland

  • Slovakia

International Drug Name Search

Tuesday, 8 February 2011

Tolbutamina




Tolbutamina may be available in the countries listed below.


Ingredient matches for Tolbutamina



Tolbutamide

Tolbutamide is reported as an ingredient of Tolbutamina in the following countries:


  • Chile

International Drug Name Search

Thursday, 20 January 2011

Trombex




Trombex may be available in the countries listed below.


Ingredient matches for Trombex



Clopidogrel

Clopidogrel is reported as an ingredient of Trombex in the following countries:


  • Bulgaria

International Drug Name Search

Wednesday, 19 January 2011

Cetirizine UCB




Cetirizine UCB may be available in the countries listed below.


Ingredient matches for Cetirizine UCB



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizine UCB in the following countries:


  • Belgium

  • Luxembourg

International Drug Name Search

Monday, 17 January 2011

Enalaprilmaleaat




Enalaprilmaleaat may be available in the countries listed below.


Ingredient matches for Enalaprilmaleaat



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalaprilmaleaat in the following countries:


  • Netherlands

International Drug Name Search

Duralyn




Duralyn may be available in the countries listed below.


Ingredient matches for Duralyn



Theophylline

Theophylline is reported as an ingredient of Duralyn in the following countries:


  • Myanmar

International Drug Name Search

Tuesday, 11 January 2011

Vepha-Gent




Vepha-Gent may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vepha-Gent



Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Vepha-Gent in the following countries:


  • Germany

International Drug Name Search

Saturday, 8 January 2011

Phéniramine




Phéniramine may be available in the countries listed below.


Ingredient matches for Phéniramine



Pheniramine

Phéniramine (DCF) is known as Pheniramine in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 6 January 2011

Xifaxan


Xifaxan is a brand name of rifaximin, approved by the FDA in the following formulation(s):


XIFAXAN (rifaximin - tablet; oral)



  • Manufacturer: SALIX PHARMS

    Approval date: May 25, 2004

    Strength(s): 200MG [RLD]


  • Manufacturer: SALIX PHARMS

    Approval date: March 24, 2010

    Strength(s): 550MG [RLD]

Has a generic version of Xifaxan been approved?


No. There is currently no therapeutically equivalent version of Xifaxan available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xifaxan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations
    Patent 7,045,620
    Issued: May 16, 2006
    Inventor(s): Viscomi; Giuseppe C. & Campana; Manuela & Braga; Dario & Confortini; Donatella & Cannata; Vincenzo & Severini; Denis & Righi; Paolo & Rosini; Goffredo
    Assignee(s): Alfa Wassermann, S.p.A.
    Crystalline polymorphous forms of the rifaximin (INN) antibiotic named rifaximin α and rifaximin β, and a poorly crystalline form named rifaximin γ have been discovered. These forms are useful in the production of medicinal preparations for oral and topical use and can be obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by the addition of water at a determinate temperature and for a determinate period of time. The crystallization is followed by drying carried out under controlled conditions until a specific water content is reached in the end product.
    Patent expiration dates:

    • June 19, 2024
      ✓ 
      Drug substance


    • June 19, 2024
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Polymorphic forms α, β, and γ of rifaximin
    Patent 7,612,199
    Issued: November 3, 2009
    Inventor(s): Viscomi; Guiseppe Glaudio & Campana; Manuela & Braga; Dario & Confortini; Donatella & Cannata; Vicenzo & Righi; Paolo & Rosini; Goffredo
    Assignee(s): Alfa Wassermann, S.p.A.
    Crystalline polymorphous forms of rifaximin (INN) antibiotic named rifaximin α and rifaximin β, and a poorly crystalline form named rifaximin γ, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention.
    Patent expiration dates:

    • June 19, 2024
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Polymorphic forms α, β and γ of rifaximin
    Patent 7,902,206
    Issued: March 8, 2011
    Inventor(s): Viscomi; Giuseppe Claudio & Campana; Manuela & Braga; Dario & Confortini; Donatella & Cannata; Vincenzo & Righi; Paolo & Rosini; Goffredo
    Assignee(s): Alfa Wassermann, S.p.A.
    Crystalline polymorphous forms of rifaximin (INN) antibiotic named rifaximin α and rifaximin β, and a poorly crystalline form named rifaximin γ, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention.
    Patent expiration dates:

    • June 19, 2024
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
    Patent 7,906,542
    Issued: March 15, 2011
    Inventor(s): Viscomi; Giuseppe Claudio & Campana; Manuela & Braga; Dario & Confortini; Donatella & Cannata; Vincenzo & Righi; Paolo & Rosini; Goffredo
    Assignee(s): Alfa Wassermann, S.p.A.
    Crystalline polymorphous forms of rifaximin (INN), referred to as rifaximin α and rifaximin β, and a poorly crystalline form referred to as rifaximin γ, useful in the production of medicaments containing rifaximin for oral and topical use and obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a fixed temperature and for a fixed period of time, followed by a drying under controlled conditions until reaching a precise water content in the end product, are the object of the invention.
    Patent expiration dates:

    • June 1, 2025
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Methods of treating travelers diarrhea and hepatic encephalopathy
    Patent 7,928,115
    Issued: April 19, 2011
    Inventor(s): Forbes; William & Bortey; Enoch
    Assignee(s): Salix Pharmaceuticals, Ltd.
    Treatment of traveler's diarrhea in subjects having hepatic encephalopathy using rifaximin is disclosed.
    Patent expiration dates:

    • July 24, 2029
      ✓ 
      Patent use: METHOD OF TREATING TRAVELERS' DIARRHEA



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • March 24, 2013 - NEW PRODUCT

    • March 24, 2017 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Xifaxan Consumer Information (Drugs.com)
  • Xifaxan Consumer Information (Wolters Kluwer)
  • Xifaxan Consumer Information (Cerner Multum)
  • Xifaxan Advanced Consumer Information (Micromedex)
  • Xifaxan AHFS DI Monographs (ASHP)
  • Rifaximin Consumer Information (Wolters Kluwer)
  • Rifaximin Consumer Information (Cerner Multum)
  • Rifaximin Advanced Consumer Information (Micromedex)
  • Rifaximin AHFS DI Monographs (ASHP)